ERBB2 and cancer: To reach the final list of genes, 859 samples were analyzed at the discovery stage, consisting of 417 mammary tumors (different histopathologies), 41 breast lines (luminal, basal, HER2, and non-tumoral), and 401 control samples (individuals with conditions other than cancer).